Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGINTERVENTIONAL

3D OPTIMIZED WMN MPRAGE Increased Detection of Focal Spinal Cord Lesion in Multiple Sclerosis (WHINUME)

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

The aim of this study is to compare the 3D OPTIMIZED MPRAGE WMN sequence to "conventional sequences" used in spinal cord analysis. The patients will be explored at the cervical level with the conventional 2D sagittal T2 FSE, 2D sagittal STIR, 2D sagittal PSIR, 3D T1 MPRAGE sequences, and the sequence of interest 3D sagittal OPTIMIZED WMN MPRAGE and 3D axial OPTIMIZED WMN MPRAGE. At the thoracic level, with the conventional 2D sagittal T2 FSE, 2D sagittal STIR, 3D T1 MPRAGE sequences and the sequence of interest 3D sagittal OPTIMIZED WMN MPRAGE.

Who May Be Eligible (Plain English)

Who May Qualify: - Patients older than 18 years old - CIS or RRMS - Medullary symptomatology less than 6 months - With or without an objective lesion on a subsequent MRI scan - Signed the willing to sign a consent form Who Should NOT Join This Trial: - Pregnant or potentially pregnant women - Breastfeeding woman - Contraindications to MRI - Other diagnosis (Neuro-myelitis spectrum disease or Progressive Multiple Sclerosis) - Surgical history on the spinal cord or lumbar spine - Patient under legal protection Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Patients older than 18 years old * CIS or RRMS * Medullary symptomatology less than 6 months * With or without an objective lesion on a subsequent MRI scan * Signed the Informed Consent Exclusion Criteria: * Pregnant or potentially pregnant women * Breastfeeding woman * Contraindications to MRI * Other diagnosis (Neuro-myelitis spectrum disease or Progressive Multiple Sclerosis) * Surgical history on the spinal cord or lumbar spine * Patient under legal protection

Treatments Being Tested

DEVICE

3D OPTIMIZED WMN MPRAGE

* At the cervical level the conventional data set: 2D Sagittal T2 FSE/ 2D Sagittal STIR / 2D Sagittal PSIR / 3D MPRAGE and the 3D OPTIMIZED MPRAGE WMN data set with sagittal and axial acquisition. * At the thoracic level the conventional data set: 2D Sagittal T2 FSE/ 2D Sagittal STIR / 3D MPRAGE and the 3D Sagittal OPTIMIZED MPRAGE WMN data set.

Locations (1)

CHU de Bordeaux
Bordeaux, France